Analytical Data
-
Gene name
NET
- Application
-
Alternative Names
SLC6A2; NAT1; NET; NET1; Sodium-dependent noradrenaline transporter; Noradrenaline Transporter; Solute Carrier Family 6 member 2; Neurotransmitter transporter; Noradrenalin
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O55192
-
Expression Region
Met1~Lys135
-
Molecular Weight
30kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of NET (neutrophil extracellular traps) recombinant proteins has gained significant attention in recent years due to their critical role in the immune response. NETs areWebs of DNA and proteins released by neutrophils to trap and neutralize pathogens, thereby preventing the spread of infections. However, the uncontrolled formation of NETs has been linked to a variety of inflammatory diseases and autoimmune disorders, making it imperative to understand their molecular composition and mechanisms of action. Researchers have been focusing on isolating and characterizing the key components of NETs, including specific proteins such as histones, enzymes, and antimicrobial peptides, through recombinant DNA technology. This approach allows scientists to produce these proteins in a controlled environment, facilitating in-depth analysis of their functions and interactions. Furthermore, the development of NET recombinant proteins holds potential for therapeutic applications, as they could serve as targets for new drugs or as biological agents to modulate immune responses. As the field advances, a deeper understanding of NET biology promises to enhance our ability to harness their protective functions while mitigating their contribution to pathologies.
